4-(2,2,2-Trifluoroethyl)aniline hydrochloride, 250mg

1,5-Naphthyridine, 95.0%, 10g

4-Chloropyrimidine hydrochloride, 97.0%, 5g

4-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 1g

Hexanitrocobaltate(III) de sodium, AR, ACS, 25 g, emballage plastique.

4-(furan-2-yl)-6-(5-methylfuran-2-yl)pyrimidin-2-amine, 95.0%, 2g

6,8-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 98%, 1g

(2E)-1-(2-methoxyphenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

4,4-Dimethoxy-3-oxo-butyric acid methyl ester, 95.0%, 100g

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol, 97.0%, 5g

(S)-1-(3-Bromobenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

1-(sec-Butyl)-4-nitrobenzene, 95.0%, 25g

4-(4-Bromo-3-formylphenoxy)benzonitrile, 95.0%, 1g